1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray

Introduction: Subcutaneous glucose sensors using introducer needles have been well characterized. Robust microsensors are required for a less invasive approach, accessing interstitial glucose in the dermis. Advancements in semiconductor manufacturing have facilitated new sensing technologies using a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1
Hauptverfasser: CHRISTIANSEN, MARK P., BHAVARAJU, NARESH C., GOTTLIEB, REBECCA, CAMPBELL, ALAN, SATTAYASAMITSATHIT, SIRILAK, BRISTER, MARK C., NOGUEIRA, KEITH, VANDENBERG, AMY L., YANG, RICH, TANGNEY, JARED R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page 1
container_title Diabetes (New York, N.Y.)
container_volume 73
creator CHRISTIANSEN, MARK P.
BHAVARAJU, NARESH C.
GOTTLIEB, REBECCA
CAMPBELL, ALAN
SATTAYASAMITSATHIT, SIRILAK
BRISTER, MARK C.
NOGUEIRA, KEITH
VANDENBERG, AMY L.
YANG, RICH
TANGNEY, JARED R.
description Introduction: Subcutaneous glucose sensors using introducer needles have been well characterized. Robust microsensors are required for a less invasive approach, accessing interstitial glucose in the dermis. Advancements in semiconductor manufacturing have facilitated new sensing technologies using arrays of silicon microsensors on a wearable patch without introducer needles. Several independent electrodes on the microarray chip support redundancy and reliability. The objective of this study was to evaluate the performance of a calibration-free, intradermal glucose sensor, compared to a gold standard. Methods: A 5-day study was conducted at two US sites evaluating the device in persons with Diabetes. Intradermal glucose sensors were placed on the volar forearm or upper arm. All subjects participated in one clinic day on Day 1, 3, or 5 of wear. Venous blood was obtained every 15 minutes for 8 hours and analyzed with the YSI (YSI Inc, Yellow Springs, Ohio) 2300 Stat Plus. A prospective, calibration-free algorithm was used. Results: 19 subjects with Type 1 diabetes ages 19 to 70 were studied. Mean Absolute Relative Difference (MARD) was 10.1% compared to YSI (n=388). 83.2% of paired points were within 20% of YSI and 100% were within Clark Error Grid A+B regions. Conclusion: The intradermal glucose sensor demonstrated accurate tracking and trending of glucose levels compared to the gold standard laboratory analyzer.
doi_str_mv 10.2337/db24-1928-LB
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3100300758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3100300758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c658-88100f601da4f64cbba9a657c81ac8e95508a6af0056d6814604d85b8e9a64053</originalsourceid><addsrcrecordid>eNotkFFLwzAQx4MoOKdvfoCAr0YvTZOmvrmxzUGHD07wLVzbVDK6Zibdw769LRsHdw_343_Hj5BHDi-JENlrXSYp43miWTG7IhOei5yJJPu5JhMAnjCe5dktuYtxBwBqqAnBC_5GlxajK13r-hP1DZ1j68qAvfMdWwZr6brrA9Y27LGlq_ZY-Wjpxneu98F1v_Q7jh3pl-2iD3TjquAxBDzdk5sG22gfLnNKtsvFdv7Bis_Vev5esEpJzbTmAI0CXmPaqLQqS8xRyazSHCttcylBo8IGQKpaaZ4qSGsty2GFKgUppuTpHHsI_u9oY292_hi64aIRQ7QAyKQeqOczNXwXY7CNOQS3x3AyHMzo0IwOzSjFFDPxD96OYxE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100300758</pqid></control><display><type>article</type><title>1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>CHRISTIANSEN, MARK P. ; BHAVARAJU, NARESH C. ; GOTTLIEB, REBECCA ; CAMPBELL, ALAN ; SATTAYASAMITSATHIT, SIRILAK ; BRISTER, MARK C. ; NOGUEIRA, KEITH ; VANDENBERG, AMY L. ; YANG, RICH ; TANGNEY, JARED R.</creator><creatorcontrib>CHRISTIANSEN, MARK P. ; BHAVARAJU, NARESH C. ; GOTTLIEB, REBECCA ; CAMPBELL, ALAN ; SATTAYASAMITSATHIT, SIRILAK ; BRISTER, MARK C. ; NOGUEIRA, KEITH ; VANDENBERG, AMY L. ; YANG, RICH ; TANGNEY, JARED R.</creatorcontrib><description>Introduction: Subcutaneous glucose sensors using introducer needles have been well characterized. Robust microsensors are required for a less invasive approach, accessing interstitial glucose in the dermis. Advancements in semiconductor manufacturing have facilitated new sensing technologies using arrays of silicon microsensors on a wearable patch without introducer needles. Several independent electrodes on the microarray chip support redundancy and reliability. The objective of this study was to evaluate the performance of a calibration-free, intradermal glucose sensor, compared to a gold standard. Methods: A 5-day study was conducted at two US sites evaluating the device in persons with Diabetes. Intradermal glucose sensors were placed on the volar forearm or upper arm. All subjects participated in one clinic day on Day 1, 3, or 5 of wear. Venous blood was obtained every 15 minutes for 8 hours and analyzed with the YSI (YSI Inc, Yellow Springs, Ohio) 2300 Stat Plus. A prospective, calibration-free algorithm was used. Results: 19 subjects with Type 1 diabetes ages 19 to 70 were studied. Mean Absolute Relative Difference (MARD) was 10.1% compared to YSI (n=388). 83.2% of paired points were within 20% of YSI and 100% were within Clark Error Grid A+B regions. Conclusion: The intradermal glucose sensor demonstrated accurate tracking and trending of glucose levels compared to the gold standard laboratory analyzer.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db24-1928-LB</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Calibration ; Chemoreception ; Dermis ; Diabetes ; Diabetes mellitus (insulin dependent) ; Glucose ; Glucose monitoring ; Sensors</subject><ispartof>Diabetes (New York, N.Y.), 2024-06, Vol.73 (Supplement_1), p.1</ispartof><rights>Copyright American Diabetes Association Jun 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>CHRISTIANSEN, MARK P.</creatorcontrib><creatorcontrib>BHAVARAJU, NARESH C.</creatorcontrib><creatorcontrib>GOTTLIEB, REBECCA</creatorcontrib><creatorcontrib>CAMPBELL, ALAN</creatorcontrib><creatorcontrib>SATTAYASAMITSATHIT, SIRILAK</creatorcontrib><creatorcontrib>BRISTER, MARK C.</creatorcontrib><creatorcontrib>NOGUEIRA, KEITH</creatorcontrib><creatorcontrib>VANDENBERG, AMY L.</creatorcontrib><creatorcontrib>YANG, RICH</creatorcontrib><creatorcontrib>TANGNEY, JARED R.</creatorcontrib><title>1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray</title><title>Diabetes (New York, N.Y.)</title><description>Introduction: Subcutaneous glucose sensors using introducer needles have been well characterized. Robust microsensors are required for a less invasive approach, accessing interstitial glucose in the dermis. Advancements in semiconductor manufacturing have facilitated new sensing technologies using arrays of silicon microsensors on a wearable patch without introducer needles. Several independent electrodes on the microarray chip support redundancy and reliability. The objective of this study was to evaluate the performance of a calibration-free, intradermal glucose sensor, compared to a gold standard. Methods: A 5-day study was conducted at two US sites evaluating the device in persons with Diabetes. Intradermal glucose sensors were placed on the volar forearm or upper arm. All subjects participated in one clinic day on Day 1, 3, or 5 of wear. Venous blood was obtained every 15 minutes for 8 hours and analyzed with the YSI (YSI Inc, Yellow Springs, Ohio) 2300 Stat Plus. A prospective, calibration-free algorithm was used. Results: 19 subjects with Type 1 diabetes ages 19 to 70 were studied. Mean Absolute Relative Difference (MARD) was 10.1% compared to YSI (n=388). 83.2% of paired points were within 20% of YSI and 100% were within Clark Error Grid A+B regions. Conclusion: The intradermal glucose sensor demonstrated accurate tracking and trending of glucose levels compared to the gold standard laboratory analyzer.</description><subject>Calibration</subject><subject>Chemoreception</subject><subject>Dermis</subject><subject>Diabetes</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>Sensors</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNotkFFLwzAQx4MoOKdvfoCAr0YvTZOmvrmxzUGHD07wLVzbVDK6Zibdw769LRsHdw_343_Hj5BHDi-JENlrXSYp43miWTG7IhOei5yJJPu5JhMAnjCe5dktuYtxBwBqqAnBC_5GlxajK13r-hP1DZ1j68qAvfMdWwZr6brrA9Y27LGlq_ZY-Wjpxneu98F1v_Q7jh3pl-2iD3TjquAxBDzdk5sG22gfLnNKtsvFdv7Bis_Vev5esEpJzbTmAI0CXmPaqLQqS8xRyazSHCttcylBo8IGQKpaaZ4qSGsty2GFKgUppuTpHHsI_u9oY292_hi64aIRQ7QAyKQeqOczNXwXY7CNOQS3x3AyHMzo0IwOzSjFFDPxD96OYxE</recordid><startdate>20240614</startdate><enddate>20240614</enddate><creator>CHRISTIANSEN, MARK P.</creator><creator>BHAVARAJU, NARESH C.</creator><creator>GOTTLIEB, REBECCA</creator><creator>CAMPBELL, ALAN</creator><creator>SATTAYASAMITSATHIT, SIRILAK</creator><creator>BRISTER, MARK C.</creator><creator>NOGUEIRA, KEITH</creator><creator>VANDENBERG, AMY L.</creator><creator>YANG, RICH</creator><creator>TANGNEY, JARED R.</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20240614</creationdate><title>1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray</title><author>CHRISTIANSEN, MARK P. ; BHAVARAJU, NARESH C. ; GOTTLIEB, REBECCA ; CAMPBELL, ALAN ; SATTAYASAMITSATHIT, SIRILAK ; BRISTER, MARK C. ; NOGUEIRA, KEITH ; VANDENBERG, AMY L. ; YANG, RICH ; TANGNEY, JARED R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c658-88100f601da4f64cbba9a657c81ac8e95508a6af0056d6814604d85b8e9a64053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Calibration</topic><topic>Chemoreception</topic><topic>Dermis</topic><topic>Diabetes</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>Sensors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHRISTIANSEN, MARK P.</creatorcontrib><creatorcontrib>BHAVARAJU, NARESH C.</creatorcontrib><creatorcontrib>GOTTLIEB, REBECCA</creatorcontrib><creatorcontrib>CAMPBELL, ALAN</creatorcontrib><creatorcontrib>SATTAYASAMITSATHIT, SIRILAK</creatorcontrib><creatorcontrib>BRISTER, MARK C.</creatorcontrib><creatorcontrib>NOGUEIRA, KEITH</creatorcontrib><creatorcontrib>VANDENBERG, AMY L.</creatorcontrib><creatorcontrib>YANG, RICH</creatorcontrib><creatorcontrib>TANGNEY, JARED R.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHRISTIANSEN, MARK P.</au><au>BHAVARAJU, NARESH C.</au><au>GOTTLIEB, REBECCA</au><au>CAMPBELL, ALAN</au><au>SATTAYASAMITSATHIT, SIRILAK</au><au>BRISTER, MARK C.</au><au>NOGUEIRA, KEITH</au><au>VANDENBERG, AMY L.</au><au>YANG, RICH</au><au>TANGNEY, JARED R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2024-06-14</date><risdate>2024</risdate><volume>73</volume><issue>Supplement_1</issue><spage>1</spage><pages>1-</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Introduction: Subcutaneous glucose sensors using introducer needles have been well characterized. Robust microsensors are required for a less invasive approach, accessing interstitial glucose in the dermis. Advancements in semiconductor manufacturing have facilitated new sensing technologies using arrays of silicon microsensors on a wearable patch without introducer needles. Several independent electrodes on the microarray chip support redundancy and reliability. The objective of this study was to evaluate the performance of a calibration-free, intradermal glucose sensor, compared to a gold standard. Methods: A 5-day study was conducted at two US sites evaluating the device in persons with Diabetes. Intradermal glucose sensors were placed on the volar forearm or upper arm. All subjects participated in one clinic day on Day 1, 3, or 5 of wear. Venous blood was obtained every 15 minutes for 8 hours and analyzed with the YSI (YSI Inc, Yellow Springs, Ohio) 2300 Stat Plus. A prospective, calibration-free algorithm was used. Results: 19 subjects with Type 1 diabetes ages 19 to 70 were studied. Mean Absolute Relative Difference (MARD) was 10.1% compared to YSI (n=388). 83.2% of paired points were within 20% of YSI and 100% were within Clark Error Grid A+B regions. Conclusion: The intradermal glucose sensor demonstrated accurate tracking and trending of glucose levels compared to the gold standard laboratory analyzer.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db24-1928-LB</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2024-06, Vol.73 (Supplement_1), p.1
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_journals_3100300758
source EZB-FREE-00999 freely available EZB journals
subjects Calibration
Chemoreception
Dermis
Diabetes
Diabetes mellitus (insulin dependent)
Glucose
Glucose monitoring
Sensors
title 1928-LB: Feasibility of Calibration-Free Intradermal Glucose Monitoring Using a Sensor Microarray
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T04%3A37%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1928-LB:%20Feasibility%20of%20Calibration-Free%20Intradermal%20Glucose%20Monitoring%20Using%20a%20Sensor%20Microarray&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=CHRISTIANSEN,%20MARK%20P.&rft.date=2024-06-14&rft.volume=73&rft.issue=Supplement_1&rft.spage=1&rft.pages=1-&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db24-1928-LB&rft_dat=%3Cproquest_cross%3E3100300758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3100300758&rft_id=info:pmid/&rfr_iscdi=true